A Novel Circular RNA, circ_0005394, Predicts Unfavorable Prognosis and Contributes to Hepatocellular Carcinoma Progression by Regulating miR-507/E2F3 and miR-515-5p/CXCL6 Signaling Pathways

References

• Kulik L, El-Serag HB. Epidemiology and management of hepatocellular carcinoma. Gastroenterology. 2019;156(2):477–491. doi:10.1053/j.gastro.2018.08.06530367835
   PubMed Web of Science ®Google Scholar
• Singal AG, El-Serag HB. Hepatocellular carcinoma from epidemiology to prevention: translating knowledge into practice. Clin Gastroenterol Hepatol. 2015;13(12):2140–2151. doi:10.1016/j.cgh.2015.08.01426284591
   PubMed Web of Science ®Google Scholar
• Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66(4):271–289. doi:10.3322/caac.2134927253694
   PubMed Web of Science ®Google Scholar
• Meng S, Zhou H, Feng Z, et al. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer. 2017;16(1):94. doi:10.1186/s12943-017-0663-228535767
   PubMed Web of Science ®Google Scholar
• Xu Y, Yao Y, Zhong X, et al. Downregulated circular RNA hsa_circ_0001649 regulates proliferation, migration and invasion in cholangiocarcinoma cells. Biochem Biophys Res Commun. 2018;496(2):455–461. doi:10.1016/j.bbrc.2018.01.07729337065
   PubMed Web of Science ®Google Scholar
• Su H, Lin F, Deng X, et al. Profiling and bioinformatics analyses reveal differential circular RNA expression in radioresistant esophageal cancer cells. J Transl Med. 2016;14(1):225. doi:10.1186/s12967-016-0977-727465405
   PubMed Web of Science ®Google Scholar
• Chen L, Zhang S, Wu J, et al. circRNA_100290 plays a role in oral cancer by functioning as a sponge of the miR-29 family. Oncogene. 2017;36:4551–4561.28368401
   PubMed Web of Science ®Google Scholar
• Tan WL, Lim BT, Anene-Nzelu CG, et al. A landscape of circular RNA expression in the human heart. Cardiovasc Res. 2017;113(3):298–309. doi:10.1093/cvr/cvw25028082450
   PubMed Web of Science ®Google Scholar
• Zou M, Huang C, Li X, et al. Circular RNA expression profile and potential function of hsa_circRNA_101238 in human thoracic aortic dissection. Oncotarget. 2017;8(47):81825–81837. doi:10.18632/oncotarget.1899829137225
   PubMedGoogle Scholar
• Zhao Y, Alexandrov PN, Jaber V, Lukiw WJ. Deficiency in the Ubiquitin Conjugating Enzyme UBE2A in Alzheimer’s Disease (AD) is linked to deficits in a natural circular miRNA-7 sponge (circRNA; ciRS-7). Genes (Basel). 2016;7.
   Web of Science ®Google Scholar
• Li LJ, Zhao W, Tao SS, et al. Competitive endogenous RNA network: potential implication for systemic lupus erythematosus. Expert Opin Ther Targets. 2017;21:639–648. doi:10.1080/14728222.2017.131993828406715
   PubMed Web of Science ®Google Scholar
• Yu J, Yang M, Zhou B, et al. CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p/TXNDC5 signaling pathway. Clin Sci (Lond). 2019;11:8182–8203.
   Google Scholar
• Xu L, Feng X, Hao X, et al. CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth. J Exp Clin Cancer Res. 2019;38(1):98. doi:10.1186/s13046-019-1041-230795787
   PubMed Web of Science ®Google Scholar
• Mao W, Huang X, Wang L, et al. Circular RNA hsa_circ_0068871 regulates FGFR3 expression and activates STAT3 by targeting miR-181a-5p to promote bladder cancer progression. J Exp Clin Cancer Res. 2019;38(1):169. doi:10.1186/s13046-019-1136-930999937
   PubMed Web of Science ®Google Scholar
• Li X, He M, Guo J, Cao T. Upregulation of circular RNA circ-ERBB2 predicts unfavorable prognosis and facilitates the progression of gastric cancer via miR-503/CACUL1 and miR-637/MMP-19 signaling. Biochem Biophys Res Commun. 2019;511(4):926–930. doi:10.1016/j.bbrc.2019.03.01030853181
   PubMed Web of Science ®Google Scholar
• Bossi L, Figueroa-Bossi N. Competing endogenous RNAs: a target-centric view of small RNA regulation in bacteria. Nat Rev Microbiol. 2016;14(12):775–784. doi:10.1038/nrmicro.2016.12927640758
   PubMed Web of Science ®Google Scholar
• Abdollahzadeh R, Daraei A, Mansoori Y, Sepahvand M, Amoli MM, Tavakkoly-Bazzaz J. Competing endogenous RNA (ceRNA) cross talk and language in ceRNA regulatory networks: A new look at hallmarks of breast cancer. J Cell Physiol. 2019;234(7):10080–10100. doi:10.1002/jcp.2794130537129
   PubMed Web of Science ®Google Scholar
• Zhu Y, Bian Y, Zhang Q, et al. Construction and analysis of dysregulated lncRNA-associated ceRNA network in colorectal cancer. J Cell Biochem. 2019;120(6):9250–9263. doi:10.1002/jcb.2820130525245
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ke X, Liu J, et al. Characterization of circRNA-associated ceRNA networks in patients with nonvalvular persistent atrial fibrillation. Mol Med Rep. 2019;19(1):638–650. doi:10.3892/mmr.2018.969530483740
   PubMed Web of Science ®Google Scholar
• Wang WL, Yang Z, Zhang YJ, et al. Competing endogenous RNA analysis reveals the regulatory potency of circRNA_036186 in HNSCC. Int J Oncol. 2018;53(4):1529–1543. doi:10.3892/ijo.2018.449930066847
   PubMed Web of Science ®Google Scholar
• Jia L, Liu W, Cao B, Li H, Yin C. MiR-507 inhibits the migration and invasion of human breastcancer cells through Flt-1 suppression. Oncotarget. 2016;7(24):36743–36754. doi:10.18632/oncotarget.916327167339
   PubMedGoogle Scholar
• Wei Y, Sun Q, Zhao L, et al. LncRNA UCA1-miR-507-FOXM1 axis is involved in cell proliferation, invasion and G0/G1 cell cycle arrest in melanoma. Med Oncol. 2016;33(8):88. doi:10.1007/s12032-016-0804-227389544
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhou J, Xue D, Li Z, Liu Y, Dong L. MiR-515-5p acts as a tumor suppressor via targeting TRIP13 in prostate cancer. Int J Biol Macromol. 2019;129:227–232. doi:10.1016/j.ijbiomac.2019.01.12730685303
   PubMed Web of Science ®Google Scholar
• Li J, Tang Z, Wang H, et al. CXCL6 promotes non-small cell lung cancer cell survival and metastasis via down-regulation of miR-515-5p. Biomed Pharmacother. 2018;97:1182–1188. doi:10.1016/j.biopha.2017.11.00429136957
   PubMed Web of Science ®Google Scholar
• Pardo OE, Castellano L, Munro CE, et al. miR-515-5p controls cancer cell migration through MARK 4 regulation. EMBO Rep. 2016;17(4):570–584. doi:10.15252/embr.20154097026882547
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang X, Huang H, Wang Y, Zhang F, Wang S. Hsa_circ_0067997 promotes the progression of gastric cancer by inhibition of miR-515-5p and activation of X chromosome-linked inhibitor of apoptosis (XIAP). Artif Cells Nanomed Biotechnol. 2019;47(1):308–318. doi:10.1080/21691401.2018.155378730688097
   PubMed Web of Science ®Google Scholar
• DeGregori J. The genetics of the E2F family of transcription factors: shared functions and unique roles. Biochim Biophys Acta. 2002;1602(2):131–150. doi:10.1016/s0304-419x(02)00051-312020800
   PubMed Web of Science ®Google Scholar
• Martinez LA, Goluszko E, Chen HZ, et al. E2F3 is a mediator of DNA damage-induced apoptosis. Mol Cell Biol. 2010;30(2):524–536. doi:10.1128/MCB.00938-0919917728
   PubMed Web of Science ®Google Scholar
• Nahle Z, Polakoff J, Davuluri RV, et al. Direct coupling of the cell cycle and cell death machinery by E2F. Nat Cell Biol. 2002;4(11):859–864. doi:10.1038/ncb86812389032
   PubMed Web of Science ®Google Scholar
• Han R, Chen X, Li Y, Zhang S, Li R, Lu L. MicroRNA-34a suppresses aggressiveness of hepatocellular carcinoma by modulating E2F1, E2F3, and Caspase-3. Cancer Manag Res. 2019;11:2963–2976. doi:10.2147/CMAR.S20266431114344
   PubMed Web of Science ®Google Scholar
• Wolf M, Delgado MB, Jones SA, Dewald B, Clark-Lewis I, Baggiolini M. Granulocyte chemotactic protein 2 acts via both Il-8 receptors, Cxcr1 and Cxcr2. Eur J Immunol. 1998;28(1):164–170. doi:10.1002/(SICI)1521-4141(199801)28:01<164::AID-IMMU164>3.0.CO;2-S9485196
   PubMed Web of Science ®Google Scholar
• Liu G, An L, Zhang H, Du P, Sheng Y. Activation of CXCL6/CXCR1/2 axis promotes the growth and metastasis of osteosarcoma cells in vitro and in vivo. Front Pharmacol. 2019;28:307. doi:10.3389/fphar.2019.00307
   Google Scholar